Creates provisions relating to biomarker testing

SB 1795 is a bill that creates provisions related to biomarker testing, but the provided context does not include specific details about its content, affected parties, or key mechanisms. The official abstract and recent actions (first reading on February 26, 2026) offer no concrete policy changes or implementation details. Without additional information on the bill's provisions, a detailed summary cannot be generated. The bill is currently in early legislative stages.